Investors Are Watching: The Western Union Company (NYSE:WU), Capnia, Inc. (NASDAQ:CAPN), ServiceNow, Inc. (NYSE:NOW), Cimarex Energy Co. (NYSE:XEC), Valeant Pharmaceuticals (NYSE:VRX)

On 4 August, The Western Union Company (NYSE:WU) have announced that they will be extending their more than 20-year relationship. Western Union international and domestic money transfer and money orders and bill payment services will continue to be available at more than 170 Cash Money Agent locations. The Western Union Company (NYSE:WU) belongs to Financial sector. Its net profit margin is 15.30% and weekly performance is 7.10%. On last trading day company shares ended up $20.37. The Western Union Company (NYSE:WU) distance from 50-day simple moving average (SMA50) is 0.28%.

On 27 July, Capnia, Inc. (NASDAQ:CAPN) announced it has entered into a common stock purchase agreement with Aspire Capital Fund, LLC (“Aspire Capital”).Capnia, Inc. (NASDAQ:CAPN) shares moved up 87.57% in last trading session and ended the day at $2.16. CAPN return on assets is -442.90%. Capnia, Inc. (NASDAQ:CAPN) quarterly performance is -49.37%.

ServiceNow, Inc. (NYSE:NOW) reported a second quarter net loss of $61.9 million, or 40 cents a share, on revenue of $246.72 million, up 48 percent compared to a year ago. ServiceNow, Inc. (NYSE:NOW) belongs to Technology sector. Its net profit margin is -24.60% and weekly performance is -6.22%. On last trading day company shares ended up $75.99. ServiceNow, Inc. (NYSE:NOW) distance from 50-day simple moving average (SMA50) is -1.97%.

Cimarex Energy Co. (NYSE:XEC) has been given a “BBB-” credit rating by Morningstar. The investment research firm’s “BBB-” rating suggests that the company is a moderate default risk. They also gave their stock a two star rating. Cimarex Energy Co. (NYSE:XEC) ended the last trading day at $112.85. Company weekly volatility is calculated as 4.34% and price to cash ratio as 87.43. Cimarex Energy Co. (NYSE:XEC) showed a weekly performance of 6.69%.

On 23 July, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) said it expects 2015 revenue of $10.7-billion-$11.1-billion, up from its $10.4-billion-$10.6-billion. It also raised its adjusted profit forecast to $11.50-$11.80 per share, from $10.90-$11.20.Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares decreased -5.38% in last trading session and ended the day at $248.40. VRX Gross Margin is 74.00% and its return on assets is 2.40%. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) quarterly performance is 13.81%.

Leave a Reply

Your email address will not be published. Required fields are marked *